NTRK2 and neoplasm: Consequently, biasing the melatonergic pathway to increase NAS or the NAS/melatonin ratio may result in heightened NAS activation of TrkB, leading to an increase in O-GlcNAcylation of crucial factors acting to regulate CSC and the wider tumour microenvironment.